HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
The National Institute for Dementia Education Announces Results from the “Cognitive Benefits of Photo Reminiscence Therapy for Dementia Patients” Research Study
Conducted by a coalition of organizations, including the National Institute for Dementia Education, the CERTUS Institute, Vivid-Pix, Tellegacy, and achi, the group studied the healing power of photos and concluded that Photo Reminiscence Therapy (pRT) can minimize social isolation and improve medication compliance and general cognitive performance.
Corvia Medical Reports Results from its REDUCE LAP-HF II RCT
A total of 626 patients were randomized at 89 centers across the US, Canada, Europe, Australia, and Japan.
Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results
In tandem with the publication, the study results were presented at the 2022 Annual Meeting for The Society of Thoracic Surgeons on January 30, 2022.
TRANSFORM II Randomized Controlled Trial Underway
TRANSFORM II RCT, determined to explore and evaluate the treatment options in native coronary vessels, enrolled the index patient on the 16th December 2021 at Sandro Pertini Hospital, Rome, by the team of Dr. Alessandro Sciahbasi.
FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed® Stemless IDE Enrollment in the USA
"This is not only a major milestone for FX, but for the next generation of stemless shoulder arthroplasty and the way we think about reverse total shoulder arthroplasty. As a small company, we are excited and humbled to lead the way and be the first to complete this historic study that may bring a novel device to the U.S. market which has already seen over 2000 implanted in Europe since 2015," said Baptiste Martin, CEO of FX Shoulder USA.
NEJM: New Data on COVID-19 Lung Transplants
The analysis of more than 3,000 lung transplants in the U.S. between Aug. 1, 2020, and Sept. 30, 2021, showed that during the pandemic, 7% of the nation’s lung transplants were performed to treat severe, irreversible lung damage caused by COVID-19. More than half of these patients needed ventilators or extracorporeal membrane oxygenation, or ECMO, before their transplant.
Preclinical Study Provides Guidance for Optimizing Safety and Efficacy of Endovascular Hepatic Denervation Devices to Treat Diabetes
“This study leveraged our deep experience in preclinical evaluation of denervation therapies and could not have been performed in a timely manner without the digital morphometry techniques we developed in-house. We remain excited about the potential of neuromodulation technologies and are committed to supporting further innovation in this space,” explained Rami Tzafriri, PhD, lead author and Director of Research and Innovation at CBSET.
Checkpoint Surgical Enrolls First Patient in Nerve Regeneration Clinical Study
The patient was enrolled at The Ohio State University, one of four sites actively enrolling patients in the double-blind, randomized clinical trial.
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL Sinus Implant Reduces Healthcare Resource Utilization
Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, including all-cause otolaryngologist, ER/urgent care and outpatient visits, as well as sinus-related endoscopies